Analystreport

Cellectis S.A. (NASDAQ: CLLS) had its price target lowered by analysts at Barclays PLC from $7.00 to $5.00. They now have an "overweight" rating on the stock.

Cellectis S.A. - American Depositary Shares  (CLLS) 
Last cellectis s.a. - american depositary shares earnings: 3/4 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: cellectis.com/en/investors